Literature DB >> 34507256

An Association between Inflammation and Cerebral Venous Thrombosis: A Retrospective Study.

Xifang Zhang1, Rui Ding2, Haiyan Li2, Yaqi Liu2, Weiyang Ou1, Jiangang Hu3, Yu Tian4, Qiujing Wang5.   

Abstract

OBJECTIVES: Evidence is currently accumulating for the role of inflammation in cerebral venous thrombosis (CVT). Neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), monocyte/high-density lipoprotein ratio (MHR), and systematic immune-inflammation index (SII) are easily obtainable indicators of systemic inflammations. However, there were few studies on the relationship between them and CVT. Therefore, we aimed to evaluate the connection between the occurrence of CVT and the inflammatory markers described.
MATERIALS AND METHODS: The samples from 150 participants (including 90 CVT and 60 primary headaches as controls) with similar baseline characteristics were collected in this retrospective study. The NLR, PLR, MHR, SII and file records were employed to compare CVT patients with the control group.
RESULTS: The levels of NLR (3.93 [2.27, 7.87] vs. 1.65 [1.31, 2.06], P < 0.001), PLR (149.52 [98.39, 198.82] vs. 107.34 [83.31, 129.47], P < 0.001), SII (896.84 [559.89, 1591.87] vs. 382.45 [273.51, 520.92], P < 0.001) and MHR (0.51 [0.40, 0.64] vs. 0.41 [0.29, 0.53], P = 0.001) were significantly higher in the CVT group. After multivariate logistic regression analysis, the SII degree (13.136, [5.675, 30.407], P < 0.001) and MHR degree (2.620, [1.123, 6.113], P < 0.01) were found as independent predictors of CVT.
CONCLUSIONS: NLR, PLR, SII, and MHR may be able to assist in the diagnosis of CVT which confirmed that inflammation played an important role in CVT.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cerebral venous thrombosis; Inflammation; Monocyte/high-density lipoprotein ratio; Neutrophil/lymphocyte ratio; Platelet/lymphocyte ratio; Systematic immune-inflammation index

Mesh:

Year:  2021        PMID: 34507256     DOI: 10.1016/j.jstrokecerebrovasdis.2021.106084

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  5 in total

1.  Systemic immune-inflammation index as a potential biomarker of cardiovascular diseases: A systematic review and meta-analysis.

Authors:  Zhen Ye; Tingyi Hu; Jin Wang; Ruoyi Xiao; Xibei Liao; Mengsi Liu; Zhen Sun
Journal:  Front Cardiovasc Med       Date:  2022-08-08

2.  The Efficacy of the Systemic Immune-Inflammation Index and Prognosis Nutritional Index for the Diagnosis of Venous Thromboembolism in Gastrointestinal Cancers.

Authors:  Lu Zhang; Yue Fang; Jianghao Xing; Hao Cheng; Xiaonan Sun; Zhichao Yuan; Yidan Xu; Jiqing Hao
Journal:  J Inflamm Res       Date:  2022-08-15

Review 3.  Inflammation and Severe Cerebral Venous Thrombosis.

Authors:  Shuyuan Hu; Hangil Lee; Haiping Zhao; Yuchuan Ding; Jiangang Duan
Journal:  Front Neurol       Date:  2022-07-22       Impact factor: 4.086

4.  The Diagnostic Value of the Systemic Immune-Inflammation Index for Venous Thromboembolism in Lung Cancer Patients: A Retrospective Study.

Authors:  Lu Zhang; Xiangliang Liu; Ruihan Yang; Yi Yang; Xiao Chen
Journal:  Mediators Inflamm       Date:  2022-08-22       Impact factor: 4.529

5.  Monocyte-to-high-density lipoprotein ratio and systemic inflammation response index are associated with the risk of metabolic disorders and cardiovascular diseases in general rural population.

Authors:  Pengbo Wang; Xiaofan Guo; Ying Zhou; Zhao Li; Shasha Yu; Yingxian Sun; Yu Hua
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-09       Impact factor: 6.055

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.